Fact CheckerSign in

NCT06356831Recruiting

National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis

Source: ClinicalTrials.gov · Last updated 28 Nov 2025

Brief summary (registry, in English)

National multicentric registry of a cohort of patient with suffering parietal endometriosis, carried out by a multidisciplinary radiosurgery team

Status (registry)
Recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
19 Mar 2024
Start date
15 Jun 2024
Primary completion date
31 Jul 2027
Lead sponsor
Centre Hospitalier Intercommunal Creteil
NCT number
NCT06356831

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From 15 Jun 2024 to the primary completion date, 31 Jul 2027
  • 18 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Female patient with a planned medical or surgical procedure for the duration of the study that may interfere with the proper conduct of the study.

Other illness

  • Patient with hemostasis disorders (constitutional or acquired)
  • Patient with systemic infection or localized scar infection upon inclusion.
  • Patient with a nodule of primary or secondary malignant tumor origin

Age

  • Minor patient (\< 18 years)

Other

  • Endometriosis not affecting the anterior wall of the abdomen (as deep pelvic muscle: ilio-psoas, obturators, perineal, ischio-anal fossa)
  • Pregnant patient at any trimester
  • Patient with contraindications to MRI
  • Patient unable to understand the information provided
  • Patient who is not affiliated to the social security system
  • Patient under curatorship or tutorship

Who the study is looking for

  • Presence of parietal endometriosis: with suggestive clinical and imaging criteria (MRI and ultrasound)
  • Symptomatic parietal endometriosis (VAS \> 3 OR bothersome bleeding OR reported impact on quality of life)

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (18)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU Bordeaux
Coordinator of this site? Confirm its status
BordeauFranceRecruiting
Clinique Tivoli
Coordinator of this site? Confirm its status
BordeauxFranceRecruiting
CHU Clermont-Ferrand
Coordinator of this site? Confirm its status
Clermont-FerrandFranceRecruiting
Chi Creteil
Coordinator of this site? Confirm its status
CréteilFranceRecruiting
Lyon Hôpital Sud
Coordinator of this site? Confirm its status
LyonFranceRecruiting
Lyon Louis Pradel
Coordinator of this site? Confirm its status
LyonFranceActive, not recruiting
Lyon Hôpital La Croix Rousse
Coordinator of this site? Confirm its status
LyonFranceRecruiting
APHM - Hopital Nord
Coordinator of this site? Confirm its status
MarseilleFranceActive, not recruiting
APHP-Hôpital la Conception La Timone
Coordinator of this site? Confirm its status
MarseilleFranceRecruiting
CHU Montpellier
Coordinator of this site? Confirm its status
MontpellierFranceRecruiting
CHU Nime
Coordinator of this site? Confirm its status
NîmesFranceRecruiting
APHP Cochin-Port Royal
Coordinator of this site? Confirm its status
ParisFranceRecruiting
APHP La Pitié
Coordinator of this site? Confirm its status
ParisFranceRecruiting
AP-HP Tenon
Coordinator of this site? Confirm its status
ParisFranceRecruiting
AP-HP Hopital Europeen Georges Pompidou
Coordinator of this site? Confirm its status
ParisFranceRecruiting
CHU Strasbourg
Coordinator of this site? Confirm its status
StrasbourgFranceEnrolling by invitation
CHU Toulouse
Coordinator of this site? Confirm its status
ToulouseFranceActive, not recruiting
CH Valencienne
Coordinator of this site? Confirm its status
ValenciennesFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.